DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL)

SUN PHARMACEUTICAL INDUSTRIES INC has recalled DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on June 17, 2026 and was initiated on May 12, 2026. It is classified as a Class I recall, which means there is a reasonable chance that using this product could cause serious health problems or death.

Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.

What was recalled?

This recall covers DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), with approximately 675 vials affected. The company behind the recall is SUN PHARMACEUTICAL INDUSTRIES INC, based in Princeton, NJ. The FDA describes the product as: “DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol, Gujarat, India, ND…”

Why was DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL) recalled?

According to the FDA, the stated reason for the recall is: “Presence of Particulate matter: Particulate matter identified as glass.” In plain terms, this recall relates to foreign material.

A foreign material recall means that pieces of something which should not be in food — such as metal, plastic, or glass — may be present. These can pose a choking hazard or cause injury. Recalls like these are issued to remove the affected product before anyone is hurt.

What should you do?

If you think you may have bought DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), compare it against the product description and identifying codes (Lot HAG2581B, expires: 05/31/2027) before using it. This recall is currently listed as ongoing.

The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact SUN PHARMACEUTICAL INDUSTRIES INC or your local health authority.

About this recall

This recall was distributed in NJ. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.